Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03377387
Title Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Her2-receptor positive breast cancer

Therapies

Capecitabine + Neratinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford Connecticut 06102 United States Details
Baptist Alliance - McI Miami Florida 33143 United States Details
Memorial Sloan Kettering at Basking Ridge Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Nassau Uniondale New York 11553 United States Details
Lehigh Valley Health Network Allentown Pennsylvania 18103 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field